Kindstar Global (Beijing) Technology
Kindstar Global (Beijing) Technology, Inc. is a Chinese enterprise specializing in advanced clinical testing services. Established in 2003 and based in Wuhan, the company offers a range of esoteric diagnostic and laboratory testing services to hospitals, including tertiary care facilities. Kindstar Global focuses on the development of specialized clinical and personalized medicine, emphasizing the needs of patients and healthcare professionals while adhering to international standards and industry guidelines. The company also provides medical research, clinical trial services, and translational medicine study services to physicians, medical institutions, and pharmaceutical companies. With laboratory facilities located in Beijing, Shanghai, and Wuhan, Kindstar Global is committed to delivering comprehensive and accurate testing services, leveraging advanced technologies and innovative inspection methods to enhance healthcare outcomes.
Haixi Biotechnology is a research and development company of medical testing reagents, aiming to provide accurate testing reagents for medical special inspections, and provide complete scientific research reagents and services for biomedical researchers. Haixi is committed to the R&D, production, sales and service of medical diagnostics and biomedical research reagent products.
Universal Medicine is a technology developer in the field of immune system, dedicated to the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment, focusing on technology developers in the field of immune system . Recently announced the completion of a 30 million RMB Pre-A round of strategic financing. WinX Capital is acting as a financial advisor. This round of investment was initiated by Kangsheng Global. Ruijiang Kangsheng Fund managed by Ruijiang Investment led the investment. The investors included Spark Venture Capital and Yangtze River Source Fund. This round of funds will be mainly used for the promotion of hematological tumor MRD products and the research and development of new clinical products.
TaiLai Biosciences is a biotechnology company formed by a senior medical industry team and a cutting-edge scientific team to provide a new generation of biopsy products and services based on proprietary biomultiomics technology. TaiLai Biosciences is a provider of bio-based proprietary bio-technology multi-omics a new generation of products and services biopsy biotechnology companies. Multiomics contains huge amounts of biological information such as DNA, RNA, metabolic small molecules, proteins, and human microbiome. Multiomics technology is a technology to find the correlation between these information through bioinformatics and computational science.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.